Hint mode is switched on Switch off
For swift navigation between sections

Flerie
LEI 54930047C4A74IBXR037

PDF download

Choose all Reset all
Download Cancel
Organization name
Flerie AB
Country name
Sweden
Country of registration
Sweden
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Flerie AB is a pharmaceutical development company focusing on immunological diseases where there is an unmet medical need for new treatment options. Its portfolio includes cobitolimod and colitis.

Awards

News

07/06/2024 InDex Pharmaceuticals Gets OK to Keep Nasdaq First North Growth Market Listing Amid Reverse Takeover, Uplisting Plans
All organization news

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    54930047C4A74IBXR037
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • Organisationsnummer
    559067-6820
Registration is required to get access.